Facebook
Twitter
LinkedIn
ForwardDentistry and Medicine Conference Series – Drug-induced Osteonecrosis of the Jaw (DIONJ)
Expert faculty will address osteonecrosis of the jaw (ONJ), which was originally identified around 15 years ago as a rare and serious side effect of certain prescribed medications. This course will arm dentists with the tools to appropriately identify and manage patients with drug-induced osteonecrosis of the jaw (DIONJ) as well as discuss surgical options for this condition.
Target Audience
Dentists, Dental Specialists, Oral and Maxillofacial Surgeons, Pain Management Medicine Specialists, Neurologists, ENT Physicians, Family Medicine, Pediatricians and other healthcare practitioners.
Learning Objectives
- Discuss medical conditions and medications associated with drug-induced osteonecrosis of the jaw (DIONJ), and implement conservative measures to prevent it.
- Effectively identify cases of DIONJ and determine optimal surgical treatment option.
Pre-registration is required. Please log in to register.
Andre C. Ledoux, DMD
Oral and Maxillofacial Surgeon
Fellow, Microvascular Reconstruction
Miami, Florida
Andre C. Ledoux, DMD, has indicated that he has no relevant financial relationships to disclose and that his discussion will not include mention of investigational or off-label usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Nurse Practitioners
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.